Japanese Pharma Sales Up Due To Price Incentives For New Drugs
This article was originally published in PharmAsia News
Executive Summary
The Japan Pharmaceutical Manufacturer Association said that the sales for its 26 public member companies increased 3% to ¥5.15 trillion in the first quarter